COVID-19 vaccine: Russia files Sputnik V registration in Europe
- The vaccine has already been approved in nine countries Argentina, Belarus, Serbia and other countries
- Russia's experimental coronavirus vaccine Sputnik V is 91.4% effective in protecting people from COVID-19, according to scientists
Russian Direct Investment Fund on Wednesday said it has filed for registration of Sputnik V in the European Union. Russia's sovereign wealth fund expects it to be reviewed in February, according to its official Twitter account.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more